While China's fully automatic capsule production equipment industry is thriving in the global market with its technological advantages and cost-effectiveness, it is currently grappling with intense cost pressure. A key challenge lies in the high proportion of raw material costs, particularly stainless steel, which accounts for 51% of the total equipment production cost. The frequent and sharp fluctuations in stainless steel prices in the global commodity market have directly disrupted the profit structure of enterprises, becoming a major bottleneck restricting the sustainable development of the industry.
Stainless steel is an indispensable core material for fully automatic capsule production lines, widely used in key components such as capsule filling hoppers, conveying pipelines, forming molds, and cleaning systems. The pharmaceutical industry has stringent requirements for equipment hygiene, corrosion resistance, and structural stability-stainless steel, with its excellent antibacterial properties, rust resistance, and mechanical strength, perfectly meets these operational needs. However, the high dependence on stainless steel has made equipment manufacturers extremely sensitive to changes in its market price. Industry data shows that for a standard fully automatic hard capsule production line with an annual output of 100 million grains, the stainless steel procurement cost alone accounts for more than half of the total production investment, far exceeding the proportion of other raw materials such as electrical components (23%) and mechanical parts (16%).
The price of stainless steel is highly volatile, driven by a combination of global macroeconomic factors, changes in raw material supply, and geopolitical uncertainties. Its production relies heavily on upstream raw materials such as iron ore, nickel, and chromium, whose prices are easily affected by international trade frictions, changes in mining policies of major producing countries, and fluctuations in global demand. For instance, in the first half of 2025, affected by the tight supply of nickel ore in Indonesia and the strengthening of environmental protection policies in domestic steel mills, the domestic price of 304 stainless steel (the main type used in pharmaceutical equipment) surged by 27% within three months. This sudden price increase directly led to a 13.77% rise in the production cost of a single capsule production line for many manufacturers.
The impact of raw material price volatility on enterprise profit margins is particularly prominent. Most domestic capsule equipment manufacturers adopt a "cost-plus pricing" model, but the lag in price adjustment makes it difficult for them to fully transfer the increased costs to downstream customers in a short period. For small and medium-sized enterprises (SMEs) with relatively weak bargaining power, the pressure is even more severe. Unlike large enterprises that can rely on large-scale procurement to obtain price discounts or sign long-term supply contracts to lock in costs, SMEs often purchase raw materials in small batches at market prices, making them more vulnerable to price fluctuations. Industry insiders revealed that since 2024, the average profit margin of domestic capsule equipment SMEs has dropped from 12.3% to 8.5%, with some small enterprises even facing the risk of losses when stainless steel prices peak.
In addition to squeezing profit margins, the instability of raw material costs also hinders enterprises' investment in technological innovation. The research and development of high-end intelligent capsule production lines (such as those integrated with AI visual inspection and digital twin technologies) requires long-term and continuous capital input. However, under the pressure of rising raw material prices, many enterprises have to cut R&D budgets to ensure the stability of daily production and operation, which may slow down the overall technological upgrading pace of the industry and affect its long-term competitiveness in the global market.
Faced with this predicament, the industry has begun to explore various countermeasures. Some leading enterprises are actively optimizing their supply chain management, establishing strategic cooperative relations with stainless steel manufacturers to achieve centralized procurement and stable supply. Others are stepping up technological research to develop alternative materials with lower costs and comparable performance, or improving production processes to reduce material waste. For example, by optimizing the structural design of equipment components, some manufacturers have reduced the stainless steel usage by 8-10% without affecting product performance.
Industry experts point out that resolving the cost pressure caused by raw material price volatility requires joint efforts from the government, industry associations, and enterprises. It is suggested that the government should strengthen the regulation of the raw material market and guide enterprises to avoid risks through financial tools such as futures hedging. At the same time, enterprises should accelerate the transformation towards high-value-added products, reduce their dependence on raw material costs by improving technological content and brand value. Only in this way can China's capsule production equipment industry break through the cost bottleneck and maintain healthy and sustainable development in the fierce global competition.